{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:22:35Z","timestamp":1793420555305,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T00:00:00Z","timestamp":1367625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00198-013-2377-7","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T10:39:01Z","timestamp":1367577541000},"page":"2961-2970","source":"Crossref","is-referenced-by-count":114,"title":["Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women"],"prefix":"10.1007","volume":"24","author":[{"given":"S. H.","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.-J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W.","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,4]]},"reference":[{"key":"2377_CR1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2741\/3950","volume":"17","author":"M Jin","year":"2012","unstructured":"Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, Yang XF (2012) Uric acid, hyperuricemia and vascular diseases. Front Biosci 17:656\u2013669","journal-title":"Front Biosci"},{"key":"2377_CR2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2796.2009.02133.x","volume":"266","author":"I Holme","year":"2009","unstructured":"Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009) Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 266:558\u2013570","journal-title":"J Intern Med"},{"key":"2377_CR3","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811\u20131821","journal-title":"N Engl J Med"},{"key":"2377_CR4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","volume":"120","author":"HK Choi","year":"2007","unstructured":"Choi HK, Ford ES (2007) Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 120:442\u2013447","journal-title":"Am J Med"},{"key":"2377_CR5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0891-5849(93)90143-I","volume":"14","author":"BF Becker","year":"1993","unstructured":"Becker BF (1993) Towards the physiological function of uric acid. Free Radic Biol Med 14:615\u2013631","journal-title":"Free Radic Biol Med"},{"key":"2377_CR6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/15257770802138558","volume":"27","author":"YY Sautin","year":"2008","unstructured":"Sautin YY, Johnson RJ (2008) Uric acid: the oxidant\u2013antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 27:608\u2013619","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2377_CR7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","volume":"555","author":"CE Berry","year":"2004","unstructured":"Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555:589\u2013606","journal-title":"J Physiol"},{"key":"2377_CR8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.mehy.2007.06.018","volume":"70","author":"X Duan","year":"2008","unstructured":"Duan X, Ling F (2008) Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure? Med Hypotheses 70:578\u2013581","journal-title":"Med Hypotheses"},{"key":"2377_CR9","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1161\/01.CIR.0000041431.57222.AF","volume":"106","author":"U Landmesser","year":"2002","unstructured":"Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, Harrison DG, Hornig B, Drexler H (2002) Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 106:3073\u20133078","journal-title":"Circulation"},{"key":"2377_CR10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-2828(85)80017-1","volume":"17","author":"DE Chambers","year":"1985","unstructured":"Chambers DE, Parks DA, Patterson G, Roy R, Mccord JM, Yoshida S, Parmley LF, Downey JM (1985) Xanthine-oxidase as a source of free-radical damage in myocardial ischemia. J Mol Cell Cardiol 17:145\u2013152","journal-title":"J Mol Cell Cardiol"},{"key":"2377_CR11","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.CIR.0000017502.58595.ED","volume":"105","author":"W Doehner","year":"2002","unstructured":"Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJ, Anker SD, Hambrecht R (2002) Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 105:2619\u20132624","journal-title":"Circulation"},{"key":"2377_CR12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00005344-200109000-00005","volume":"38","author":"WS Waring","year":"2001","unstructured":"Waring WS, Webb DJ, Maxwell SRJ (2001) Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharm 38:365\u2013371","journal-title":"J Cardiovasc Pharm"},{"key":"2377_CR13","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3233\/JAD-2010-1330","volume":"19","author":"GL Bowman","year":"2010","unstructured":"Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF (2010) Uric acid as a CNS antioxidant. J Alzheimers Dis 19:1331\u20131336","journal-title":"J Alzheimers Dis"},{"key":"2377_CR14","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00415-012-6440-7","volume":"259","author":"S Paganoni","year":"2012","unstructured":"Paganoni S, Zhang M, Quiroz Zarate A, Jaffa M, Yu H, Cudkowicz ME, Wills AM (2012) Uric acid levels predict survival in men with amyotrophic lateral sclerosis. J Neurol 259:1923\u20131928","journal-title":"J Neurol"},{"key":"2377_CR15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1172\/JCI114485","volume":"85","author":"IR Garrett","year":"1990","unstructured":"Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR (1990) Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 85:632\u2013639","journal-title":"J Clin Invest"},{"key":"2377_CR16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.yexcr.2004.07.035","volume":"301","author":"H Ha","year":"2004","unstructured":"Ha H, Kwak HB, Lee SW, Jin HM, Kim HM, Kim HH, Lee ZH (2004) Reactive oxygen species mediate RANK signaling in osteoclasts. Exp Cell Res 301:119\u2013127","journal-title":"Exp Cell Res"},{"key":"2377_CR17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2003.12.073","volume":"314","author":"XC Bai","year":"2004","unstructured":"Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM, Luo SQ (2004) Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappa B. Biochem Bioph Res Co 314:197\u2013207","journal-title":"Biochem Bioph Res Co"},{"key":"2377_CR18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tox.2005.07.003","volume":"215","author":"BG Park","year":"2005","unstructured":"Park BG, Yoo CI, Kim HT, Kwon CH, Kim YK (2005) Role of mitogen-activated protein kinases in hydrogen peroxide-induced cell death in osteoblastic cells. Toxicology 215:115\u2013125","journal-title":"Toxicology"},{"key":"2377_CR19","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1210\/jc.2002-021496","volume":"88","author":"D Maggio","year":"2003","unstructured":"Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A (2003) Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88:1523\u20131527","journal-title":"J Clin Endocrinol Metab"},{"key":"2377_CR20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2474-8-124","volume":"8","author":"M S\u00e1nchez-Rodr\u00edguez","year":"2007","unstructured":"S\u00e1nchez-Rodr\u00edguez M, Ruiz-Ramos M, Correa-Mu\u00f1oz E, Mendoza-N\u00fa\u00f1ez V (2007) Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet Disord 8:124","journal-title":"BMC Musculoskelet Disord"},{"key":"2377_CR21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0009-8981(01)00766-5","volume":"318","author":"AN Sontakke","year":"2002","unstructured":"Sontakke AN, Tare RS (2002) A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin Chim Acta 318:145\u2013148","journal-title":"Clin Chim Acta"},{"key":"2377_CR22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s002239900512","volume":"63","author":"SL Hall","year":"1998","unstructured":"Hall SL, Greendale GA (1998) The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study. Calcif Tissue Int 63:183\u2013189","journal-title":"Calcif Tissue Int"},{"key":"2377_CR23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1359\/jbmr.1999.14.1.129","volume":"14","author":"H Melhus","year":"1999","unstructured":"Melhus H, Michaelsson K, Holmberg L, Wolk A, Ljunghall S (1999) Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 14:129\u2013135","journal-title":"J Bone Miner Res"},{"key":"2377_CR24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00198-006-0205-z","volume":"18","author":"L Rao","year":"2007","unstructured":"Rao L, Mackinnon E, Josse R, Murray T, Strauss A, Rao A (2007) Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women. Osteoporosis Int 18:109\u2013115","journal-title":"Osteoporosis Int"},{"key":"2377_CR25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00198-010-1308-0","volume":"22","author":"E Mackinnon","year":"2011","unstructured":"Mackinnon E, Rao A, Josse R, Rao L (2011) Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal women. Osteoporosis Int 22:1091\u20131101","journal-title":"Osteoporosis Int"},{"key":"2377_CR26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1172\/JCI200318859","volume":"112","author":"JM Lean","year":"2003","unstructured":"Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112:915\u2013923","journal-title":"J Clin Invest"},{"key":"2377_CR27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.mehy.2010.07.054","volume":"75","author":"MM Donghui","year":"2010","unstructured":"Donghui MM (2010) Moderate levels of plasma uric acid could promote fracture healing. Med Hypotheses 75:682","journal-title":"Med Hypotheses"},{"key":"2377_CR28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31\u201341","journal-title":"Nephron"},{"key":"2377_CR29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jbmr.5650100719","volume":"10","author":"D Kiel","year":"1995","unstructured":"Kiel D (1995) Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures. J Bone Miner Res 10:518\u2013523","journal-title":"J Bone Miner Res"},{"key":"2377_CR30","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148","journal-title":"J Bone Miner Res"},{"key":"2377_CR31","first-page":"1738","volume":"59","author":"M Yoneda","year":"1983","unstructured":"Yoneda M, Takatsuki K, Tomita A (1983) Parathyroid function and uric acid metabolism. Nihon Naibunpi Gakkai Zasshi 59:1738\u20131751","journal-title":"Nihon Naibunpi Gakkai Zasshi"},{"key":"2377_CR32","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar3769","volume":"14","author":"JY Hui","year":"2012","unstructured":"Hui JY, Choi JW, Mount DB, Zhu Y, Zhang Y, Choi HK (2012) The independent association between parathyroid hormone levels and hyperuricemia: a national population study. Arthritis Res Ther 14:R56. doi: 10.1186\/ar3769","journal-title":"Arthritis Res Ther"},{"key":"2377_CR33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11914-008-0003-y","volume":"6","author":"PD Miller","year":"2008","unstructured":"Miller PD (2008) Safety of parathyroid hormone for the treatment of osteoporosis. Curr Osteoporos Rep 6:12\u201316","journal-title":"Curr Osteoporos Rep"},{"key":"2377_CR34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0026-0495(98)90267-0","volume":"47","author":"S Takahashi","year":"1998","unstructured":"Takahashi S, Yamamoto T, Moriwaki Y, Tsutsumi Z, Yamakita J, Higashino K (1998) Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout. Metabolism 47:336\u2013338","journal-title":"Metabolism"},{"key":"2377_CR35","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.V441035","volume":"4","author":"R Vanholder","year":"1993","unstructured":"Vanholder R, Patel S, Hsu CH (1993) Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure. J Am Soc Nephrol 4:1035\u20131038","journal-title":"J Am Soc Nephrol"},{"key":"2377_CR36","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jbmr.286","volume":"26","author":"I Nabipour","year":"2011","unstructured":"Nabipour I, Sambrook PN, Blyth FM, Janu MR, Waite LM, Naganathan V, Handelsman DJ, Le Couteur DG, Cumming RG, Seibel MJ (2011) Serum uric acid is associated with bone health in older men: a cross\u2013sectional population\u2013based study. J Bone Miner Res 26:955\u2013964","journal-title":"J Bone Miner Res"},{"key":"2377_CR37","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/en.2004-1021","volume":"146","author":"JM Lean","year":"2005","unstructured":"Lean JM, Jagger CJ, Kirstein B, Fuller K, Chambers TJ (2005) Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146:728\u2013735","journal-title":"Endocrinology"},{"key":"2377_CR38","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.1566","volume":"27","author":"MS Hamidi","year":"2012","unstructured":"Hamidi MS, Corey PN, Cheung AM (2012) Effects of vitamin E on bone turnover markers among US postmenopausal women. J Bone Miner Res 27:1368\u20131380","journal-title":"J Bone Miner Res"},{"key":"2377_CR39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jech.51.5.479","volume":"51","author":"SG Leveille","year":"1997","unstructured":"Leveille SG, LaCroix AZ, Koepsell TD, Beresford SA, Van Belle G, Buchner DM (1997) Dietary vitamin C and bone mineral density in postmenopausal women in Washington State, USA. J Epidemiol Community Health 51:479\u2013485","journal-title":"J Epidemiol Community Health"},{"key":"2377_CR40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/en.2004-1058","volume":"146","author":"CJ Jagger","year":"2005","unstructured":"Jagger CJ, Lean JM, Davies JT, Chambers TJ (2005) Tumor necrosis factor-alpha mediates osteopenia caused by depletion of antioxidants. Endocrinology 146:113\u2013118","journal-title":"Endocrinology"},{"key":"2377_CR41","author":"C Sritara","year":"2012","unstructured":"Sritara C, Ongphiphadhanakul B, Chailurkit L, Yamwong S, Ratanachaiwong W, Sritara P (2012) Serum uric acid levels in relation to bone-related phenotypes in men and women. J Clin Densitom. doi: 10.1016\/j.jocd.2012.05.008","journal-title":"J Clin Densitom"},{"key":"2377_CR42","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bone.2012.10.025","volume":"52","author":"J Makovey","year":"2013","unstructured":"Makovey J, Macara M, Chen JS, Hayward CS, March L, Seibel MJ, Sambrook PN (2013) Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: a longitudinal study. Bone 52:400\u2013406","journal-title":"Bone"},{"key":"2377_CR43","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.clinbiochem.2009.04.001","volume":"42","author":"JP Brown","year":"2009","unstructured":"Brown JP, Albert C, Nassar BA et al (2009) Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem 42:929\u2013942","journal-title":"Clin Biochem"},{"key":"2377_CR44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00774-011-0300-x","volume":"30","author":"CS Shin","year":"2012","unstructured":"Shin CS, Kim MJ, Shim SM et al (2012) The prevalence and risk factors of vertebral fractures in Korea. J Bone Miner Metab 30:183\u2013192","journal-title":"J Bone Miner Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2377-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-013-2377-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2377-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T03:05:08Z","timestamp":1715310308000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-013-2377-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,4]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2377"],"URL":"https:\/\/doi.org\/10.1007\/s00198-013-2377-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,4]]}}}